Investor's Business Daily - Investing RSS http://ift.tt/1xGVlHr Many IBD 50 stocks are getting support at their 10-week moving averages as they continue to hold up well despite recent market turbulence. Biotech stock Gilead Sciences (GILD) is working on a 21-week consolidation with a possible buy point at 116.93. It fell just 1% last week while biotech stocks as a whole dropped 6% amid concerns that the sector is overvalued. The 368-stock Medical-Biomedical/Biotech industry was ranked No. 1 out of the 197
No comments:
Post a Comment